Purpose/Objective(s): Prospective, randomized trials support adjuvant radiation therapy (RT) for adverse pathologic features after radical prostatectomy (RP). However, adjuvant RT is not universally delivered in this setting. Criticisms of adjuvant RT include toxicity, financial costs, potential overtreatment, and effectiveness of salvage RT. The objective of this study was to construct a decision analytic model to estimate real world cost of RT vs. no RT within the context of the effectiveness of early adjuvant RT for prostate patients based on published clinical results of the Southwest Oncology Group prospective trial of adjuvant RT (SWOG 8794).
American Society for Therapeutic Radiation Oncology (ASTRO) 52nd Annual Meeting October 31 - November 4, San Diego, CA
Showalter, T. N.; Foley, K. A.; Jutkowitz, E.; Lallas, C.; Harvey, A. J.; Trabulsi, E. J.; Gomella, L. G.; Dicker, A. P.; and Pizzi, L. T.
"Costs of Early Adjuvant Radiation Therapy After Radical Prostatectomy: A Decision Analysis,"
1, Article 41.
Available at: http://jdc.jefferson.edu/bodinejournal/vol3/iss1/41